Chartwell Investment Partners, LLC Sarepta Therapeutics, Inc. Transaction History

Chartwell Investment Partners, LLC

$2.91 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$93.7 - $141.53 $1.27 Million - $1.91 Million	13,511 New	13,511 $1.75 Million
Q2 2021 Jul 19, 2021	SELL	$69.38 - $86.75 $413,782 - $517,377	-5,964 Closed	0 $0
Q1 2021 May 03, 2021	SELL	$72.25 - $168.95 $29,839 - $69,776	-413 Reduced 6.48%	5,964 $444,000
Q4 2020 Feb 09, 2021	BUY	$125.56 - $178.74 $24,358 - $34,675	194 Added 3.14%	6,377 $1.09 Million
Q3 2020 Nov 16, 2020	SELL	$127.12 - $172.34 $202,883 - $275,054	-1,596 Reduced 20.52%	6,183 $868,000
Q2 2020 Jul 29, 2020	BUY	$93.0 - $171.7 $44,454 - $82,072	478 Added 6.55%	7,779 $1.25 Million
Q1 2020 Apr 30, 2020	SELL	$82.38 - $131.64 $22,654 - $36,200	-275 Reduced 3.63%	7,301 $714,000
Q4 2019 Jan 29, 2020	SELL	$76.53 - $135.58 $63,826 - $113,073	-834 Reduced 9.92%	7,576 $978,000
Q3 2019 Oct 29, 2019	SELL	$72.81 - $156.91 $13,105 - $28,243	-180 Reduced 2.1%	8,410 $633,000
Q2 2019 Aug 19, 2019	SELL	$112.21 - $151.95 $153,615 - $208,019	-1,369 Reduced 13.75%	8,590 $1.31 Million
Q1 2019 Apr 11, 2019	SELL	$106.67 - $151.68 $3.82 Million - $5.43 Million	-35,804 Reduced 78.24%	9,959 $1.19 Million
Q4 2018 Feb 01, 2019	BUY	$97.32 - $148.76 $102,088 - $156,049	1,049 Added 2.35%	45,763 $4.99 Million
Q3 2018 Nov 08, 2018	SELL	$115.31 - $161.51 $637,779 - $893,311	-5,531 Reduced 11.01%	44,714 $7.22 Million
Q2 2018 Aug 09, 2018	SELL	$71.74 - $153.69 $4.65 Million - $9.96 Million	-64,797 Reduced 56.32%	50,245 $6.64 Million
Q1 2018 May 08, 2018	BUY	$54.02 - $82.27 $1.82 Million - $2.77 Million	33,712 Added 41.45%	115,042 $6.4 Million
Q1 2018 May 08, 2018	SELL	$54.02 - $82.27 $1.82 Million - $2.77 Million	-33,712 Reduced 29.3%	81,330 $6.03 Million
Q4 2017 Feb 08, 2018	SELL	$47.64 - $56.75 $369,114 - $439,699	-7,748 Reduced 6.31%	115,042 $6.4 Million
Q3 2017 Nov 08, 2017	BUY	$35.73 - $47.15 $4.39 Million - $5.79 Million	122,790	122,790 $5.57 Million

Others Institutions Holding SRPT

# of Institutions

529

Shares Held

84.2M

Call Options Held

2.06M

Put Options Held

1.52M

Black Rock Inc. New York, NY

10.3M
Shares

$1.23 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

8.97M
Shares

$1.07 Billion
0.02% of portfolio
Capital International Investors Los Angeles, CA

6.26M
Shares

$745 Million
0.16% of portfolio
Janus Henderson Group PLC London, X0

4.36M
Shares

$519 Million
0.29% of portfolio
State Street Corp Boston, MA

4.27M
Shares

$508 Million
0.02% of portfolio

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chartwell Investment Partners, LLC with notifications on news.

Account